Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
Menu
NET Nurse
Donate
What are NETs?
Patients & Carers
Healthcare Professionals
Get Involved
NET Nurse
Donate
What are NETs?
  • What are Neuroendocrine Cancers?
  • What are Pheos & Paras?
  • NET Symptoms
  • Causes
  • Treatments
  • Grades
National Action Plan
Patients & Carers
  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • Patient Stories
  • Share your Story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS
National Action Plan
Healthcare Professionals
  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources
National Action Plan
Get Involved
  • Advocate for Us
  • Share your Story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
National-Action-Plan-1.png
NET Nurse
Donate

Home » News » Equitable access for all NET patients

Equitable access for all NET patients

  • July 11, 2023

Senator, Wendy Askew has moved a motion to conduct a Senate Inquiry regarding Equitable Access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer.

To support this landmark inquiry we are now calling on our NETs community to help in one of two ways:

  1. Either complete and send a personal letter to the Senate Community Affairs References Committee (template included below)
  2. OR fill out your details in the form below to be included in a joint submission that NECA will create on behalf of our NETs community.


Submissions close on the 31st of August 2023, so don’t delay. 

The Terms of Reference for the inquiry are:

Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer, with particular reference to:

a. barriers to screening and diagnosis, including the impact of factors such as:

i. geographic location,
ii. cost,
iii. cultural and language barriers,
iv. type of cancer, and
v. availability of treating practitioners;

b. barriers to accessing appropriate treatment;

c. the adequacy of support services after diagnosis;

d. the adequacy of Commonwealth funding for research into rare, less common, and neuroendocrine cancer; and

e. any other related matters.

For more information regarding the inquiry, you can read Senator Wendy Askew’s full press release HERE.

Help us achieve equitable access for all NET patients.

Sending a personal letter in support of the inquiry is simple:

  1. Download the template for the Senate Inquiry via the button below.
  2. Personalise the letter with your own personal NETs story. How has your life been impacted, what barriers have you experienced first hand?
  3.  Urge the government to make lasting changes that will improve the lives of NET patients, their families and carers around Australia and upload your letter before the 31st of August 2023.

 

Full instructions can be viewed HERE  

Download a sample letter HERE

Register your details for joint submission.

If you would like to show your support, but would prefer to form part of our joint submission, please complete the form below. If you would like any of your responses to the Terms of Reference (some or all of them) to be included in the NECA submission please include these in the notes section prior to the 17th of August.

All registrations received will be included within our joint submission, which we will submit before the 31st of August 2023.

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Online survey for NET patients

September 26, 2023

Medicines Australia PharmAus event in Canberra

September 26, 2023

INCA Annual Summit 2023

September 26, 2023

Have your say on #EndGenderBias in Australia’s healthcare system

September 19, 2023
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousSenate moves motion to establish rare cancer inquiry
NextClosing the NET on Rare Cancers Article published by Melbourne UniNext

Related Posts

Online survey for NET patients

 Evaluating the impact of the Optimal Care Pathway for neuroendocrine tumors on patient care in Australia Diagnosed with a NET in 2021 or later? Share

Medicines Australia PharmAus event in Canberra

NECA attended the Medicines Australia ‘PharmAus’ event in Canberra September 6th in the Great Hall at Parliament House. This year’s theme was ‘Partnering for Future Health’,

INCA Annual Summit 2023

The International Neuroendocrine Cancer Alliance (INCA) Annual Summit was held in Bologna on the 11 & 12 September 2023. It was such a productive 2

Have your say on #EndGenderBias in Australia’s healthcare system

  The National Women’s Health Advisory Council was stood-up earlier this year to provide advice to the Australian Government on ways to improve health outcomes

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • What Are Neuroendocrine Cancers?​
  • What Are Pheos & Paras?
  • National Patient Awareness
  • What Are Neuroendocrine Cancers?​
  • What Are Pheos & Paras?
  • National Patient Awareness

Patients & Carers

  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • National Action Plan
  • Patient Stories
  • Share your story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS
  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • National Action Plan
  • Patient Stories
  • Share your story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS

Healthcare Professionals

  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources
  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources

Get Involved

  • Advocate for us
  • Share your story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
  • Advocate for us
  • Share your story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2023 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin

What's on?

How to identify a neuroendocrine cancer when it’s not part of the typical line up. A RACGP & ACN CPD accredited course.

Share this course with your healthcare professional so they can enrol in this free online course and learn more about how to diagnose and treat NETs in general practice.

Learn More